iSpecimen Inc (ISPC)
0.275
-0.02
(-5.30%)
USD |
NASDAQ |
May 01, 16:00
0.275
0.00 (0.00%)
After-Hours: 20:00
iSpecimen Cash from Investing (TTM): -7.228M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -7.228M |
September 30, 2023 | -8.147M |
June 30, 2023 | -11.27M |
March 31, 2023 | -11.64M |
December 31, 2022 | -3.191M |
September 30, 2022 | -1.854M |
June 30, 2022 | -1.372M |
Date | Value |
---|---|
March 31, 2022 | -1.162M |
December 31, 2021 | -1.038M |
September 30, 2021 | -0.9704M |
June 30, 2021 | -0.9535M |
March 31, 2021 | -1.057M |
December 31, 2020 | -1.103M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-11.64M
Minimum
Mar 2023
-0.9535M
Maximum
Jun 2021
-3.922M
Average
-1.372M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
RadNet Inc | -201.47M |
DermTech Inc | 29.86M |
23andMe Holding Co | -10.77M |
Sera Prognostics Inc | 0.438M |
Progyny Inc | -200.52M |